People · Operator

Derrell J. Porter

Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals

1
Companies
2
Filings
$10.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Biosortia Pharmaceuticals, Inc.PharmaceuticalsSeed$10.1M$25.7M2014
Operator network

Derrell J. Porter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Ross O Youngs · 2 companies · 1 sharedRoss O YoungsDerrell L. Porter · 1 companies · 1 sharedDerrell L. PorterDerrell O Porter · 1 companies · 1 sharedDerrell O PorterDouglas L. Poling · 1 companies · 1 sharedDouglas L. PolingDouglas O Poling · 1 companies · 1 sharedDouglas O PolingHenry J. Cialone · 1 companies · 1 sharedHenry J. CialoneHenry O Cialone · 1 companies · 1 sharedHenry O CialoneJohn O Ryals · 1 companies · 1 sharedJohn O RyalsKurt D. Dieck · 1 companies · 1 sharedKurt D. DieckRobert D. Kamerschen · 1 companies · 1 sharedRobert D. Kamersc…Robert O Kamerschen · 1 companies · 1 sharedRobert O Kamersch…Roger A. Vaughan · 1 companies · 1 sharedRoger A. VaughanRon O Moss · 1 companies · 1 sharedRon O MossBiosortia Pharmaceuticals, Inc. · $10.1M raisedBiosortia Pharmaceuti…Derrell J. PorterDP
Derrell J. Porter Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Derrell J. Porter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Ross O Youngs12
Roger A. Vaughan11
Kurt D. Dieck11
Henry J. Cialone11
Robert D. Kamerschen11
Derrell O Porter11
Henry O Cialone11
Robert O Kamerschen11
Douglas L. Poling11
Ron O Moss11
Derrell L. Porter11
Douglas O Poling11
John O Ryals11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.